Project Grant HT94252510662
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $2,519,334 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) aims to increase the reach of evidence-based PTSD treatment by developing and conducting a clinical trial of an AI-facilitated, web-based written exposure therapy training program. The award was granted to The University of Texas Health Science Center at San Antonio, a prominent Hispanic-serving academic medical center with extensive expertise in federal research...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This $3,150,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award was granted to The University of Texas Health Science Center at San Antonio, a Hispanic-serving academic medical institution with extensive...
This $2,317,051 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on September 15, 2023. The grant funds a clinical trial to evaluate the use of vagus nerve stimulation (VNS) paired with prolonged exposure therapy to treat chronic post-traumatic stress disorder (PTSD). The University of Texas at Dallas (UTD) and Baylor Research Institute will serve as clinical sites for the study. UTD, led by Principal Investigator...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...